Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT07198763
Active, not recruiting Not applicable

Comparison Between Conventional Rehabilitation and Conventional Rehabilitation Through Dance in Patients With COPD

NCT07198763 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2025-09-07
Last updated
2025-09-30

Condition(s) studied

Pulmonary Disease (COPD), Chronic ObstructiveDance TherapyDance

Investigational drug(s) / intervention(s)

Conventional pulmonary rehabilitation

Conventional pulmonary rehabilitation: After completing the assessments, participants will be randomly divided into two groups: Group 1, which will perform PR exercises and the Group 2, which will perform PR through dance. Both groups will have the interventions of pulmonary rehabilitation during approximately 50 minutes, for 8 weeks. The group 1 will perform five different exercises with resistance bands, with 3 sets of 1 minute each. Exercises will always begin with the lightest resistance band, and if more than 30 repetitions are observed in 1 minute, the resistance band will be replaced with one of the next highest resistance. The Group 2 will perform rehabilitation through dance using 2 different playlists. The music will be from nationally and internationally known artists. The steps will be based on the exercises performed in group 1 and will be incremented throughout each song and playlist. At the end of 8 weeks of intervention, the evaluative tests will be applied again.

Study summary

Introduction: Chronic obstructive pulmonary disease (COPD) is recognized as one of the most relevant conditions worldwide, due to its high morbidity and mortality. Patients classified by GOLD as groups B and E are strongly encouraged to participate in pulmonary rehabilitation (PR) programs. Dance has been shown to be equally or, at times, more effective as a rehabilitation strategy when compared to other types of physical activity. Objective: To compare the effect of conventional rehabilitation and the effect of conventional rehabilitation added to dance in patients with COPD. Methods: This is a conventional randomized controlled clinical trial to be carried at the Piquet Carneiro University Polyclinic, Rio de Janeiro. Patients diagnosed with COPD will be evaluated. Eligible participants will complete specific questionnaires and tests. Finally, participants will be randomly divided into two groups: one group will perform conventional PR twice a week and the other group will perform rehabilitation through dance twice a week using 2 different playlists. The music will be from nationally and internationally known artists during 8 weeks. The evaluation tests will be repeated at the end of the intervention. Expected results: It is expected that the group of individuals with COPD who perform rehabilitation through dance will obtain greater and better results in relation to exercise capacity, QoL and peripheral muscle strength when compared to the group that will carry out the intervention consisting of two days of conventional PR.

Keywords: Dance; Chronic obstructive pulmonary disease; Muscle strength; Quality of life; Rehabilitation.

Eligibility

Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients who meet the diagnostic criteria for COPD; 2. Age group over 40 years old; 3. Both genders; 4. Absence of acute exacerbation in the last 30 days; 5. Patients who are regularly using their medications. Exclusion Criteria: 1. Presence of comorbidities and cardiovascular, neurological, renal, metabolic or musculoskeletal disorders that prevent the performance of functional tests; 2. Advanced cancer; 3. Previous lung surgery; 4. Inability to understand functional tests or questionnaires applied; 5. Patients who, during the research, present an acute exacerbation of COPD, due to the time required for recovery; 6. Patients with results observed in the 6MWT \<300m.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centro Universitário Augusto Motta Rio de Janeiro Rio de Janeiro

More Centro Universitário Augusto Motta trials in Brazil

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07198763 on ClinicalTrials.gov ↗ ← All trials in Brazil